News

Boy with rare brain cancer to be treated at new NHS £125 million centre

A 15-year-old boy with a rare brain tumour will today begin world leading treatment at the NHS’s new Proton Beam Therapy centre at The Christie hospital in Manchester. Mason Kettley, from Angmering, West Sussex, was diagnosed with a brain tumour in October. Proton Beam Therapy (PBT) is a specialist form of radiotherapy that targets cancers […]

Read more

First children with cancer to begin treatment with revolutionary CAR-T therapy

The first children to receive a game-changing personalised therapy for cancer will start treatment at Great Ormond Street Hospital in London this week. A second centre, Royal Manchester Children’s Hospital, is also ready to start treating children with a rare form of leukaemia while a third, Newcastle upon Tyne Hospitals NHS Foundation Trust, is expected […]

Read more

Turnbull and Fry effect will save lives, says NHS Chief

NHS chief Simon Stevens will today thank Bill Turnbull and Stephen Fry for speaking out about their prostate cancer diagnosis and announce an injection of £10 million to increase capacity, helping services see and treat the extra people coming forward for help. The NHS is already seeing and treating more people than ever before and […]

Read more

NHS England announces groundbreaking new personalised therapy for children with cancer

NHS patients to benefit from Europe’s first full access deal on breakthrough CAR-T therapy. NHS England chief executive Simon Stevens has announced today that children and young people in England will receive a groundbreaking cancer treatment, the first in what is expected to be a rapidly expanding class of personalised cancer therapies available on the […]

Read more

NHS England strikes deal on new NICE recommended lung cancer immunotherapy drug

NHS chief Simon Stevens has today announced that NHS England has struck a deal with MSD, endorsed by NICE, to make the lung cancer drug pembrolizumab available for routine use on the NHS. New trial results show pembrolizumab extends life for certain adults with lung cancer for more than a year. Pembrolizumab is the first […]

Read more